1) The study found that the Plasmodium yoelii malaria parasite preferentially infects young red blood cells (RBCs) that express high levels of CD47.
2) Mice lacking CD47 (CD47-/- mice) were highly resistant to P. yoelii infection and developed a 9.3-fold lower peak parasitemia compared to wild-type mice.
3) Macrophages from CD47-/- mice were more effective at phagocytizing parasitized RBCs during acute infection, when parasitemia was rapidly rising, suggesting CD47 helps the parasite evade immune clearance.
Natural history of human papillomavirus infections, cytologic and histologic ...Eliana Cordero
This document summarizes the natural history of human papillomavirus (HPV) infections and their relationship to abnormal cervical cytology and histology. It discusses that most HPV infections are transient and asymptomatic, but persistent infection with high-risk HPV types can sometimes lead to precancerous lesions and cervical cancer over many years. HPV type 16 is the most common high-risk type associated with cervical cancer. Screening programs have reduced cervical cancer rates in many countries, but it remains a health issue.
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...Dr. Juan Rodriguez-Tafur
This document analyzes the association between MHC ancestral haplotypes and rates of progression to AIDS. It finds that the 8.1 and 44.2 ancestral haplotypes are associated with rapid progression to AIDS, while the 35.2 and 57.1 haplotypes are associated with slow progression. Analysis of recombinant fragments of these haplotypes identifies MHC regions within the 35.1, 35.2, and 44.2 haplotypes associated with rapid progression, and within the 44.1 and 57.1 haplotypes associated with slow progression. Previous studies identified single HLA alleles associated with progression; this study confirms the direct role of HLA-B35 in rapid progression through haplotype analysis.
Human genetic variation can influence treatment prognosis for hepatitis C virus (HCV). A single nucleotide polymorphism near the IFNL3 gene indicates natural resistance to type 1 HCV, with the T variant associated with poorer treatment outcomes. Additionally, a polymorphism in the interleukin-23 receptor gene correlates with reduced risk of HCV-related liver cancer. HCV appears to have evolved to benefit from allelic variations between geographic regions. Future treatment may focus on precise virus-genome interactions. Mapping the entire human genome could increase understanding of connections between HCV and its human host.
This study estimates the effective recombination rate and distribution of selection coefficients in HIV using time series sequence data from infected patients. By examining how new haplotype combinations arise between time points, the researchers estimated an effective recombination rate of 1.460.661025 recombinations per site and generation. They also found evidence that at least 15% of observed non-synonymous mutations are selected for at a rate exceeding 0.8% per generation. This provides quantitative parameters for understanding HIV evolution within patients over time.
This document compares the allele frequencies of 15 Plasmodium falciparum merozoite antigen genes in malaria infections sampled in Kenya in 2007 and 2008. It finds fluctuating allele frequencies in codons 147 and 148 of the reticulocyte-binding homologue 5 (Rh5) gene over this period in uncomplicated malaria infections. However, the dominant YH haplotype was stable over multiple years in asymptomatic and complicated infections. A regression analysis found the chance of the less common HD haplotype decreased over time from 2007 to 2009 in uncomplicated and asymptomatic infections.
Viruses can cause cancer through several mechanisms. Small DNA tumor viruses like HPV and adenovirus often integrate into the host genome and express early genes that promote cell cycle progression and prevent apoptosis. This leads to uncontrolled cell growth. Herpesviruses like EBV and KSHV can cause cancer during their latency phase by expressing genes that induce cell activation and proliferation programs. Chronic viral infections may also cause cancer over long periods through prolonged inflammation. Studying virus-associated cancers provides insights into cancer mechanisms and potential new targets for treatment.
Lombardi et al: XMRV/CFS Inflammatory Signaturedegarden
This document summarizes a study that identified a signature of 10 cytokines and chemokines that can correctly identify patients with chronic fatigue syndrome (CFS) associated with xenotropic murine leukemia virus-related virus (XMRV) infection. The study used Luminex multi-analyte profiling to measure cytokine and chemokine levels in the plasma of 118 CFS patients who tested positive for XMRV, compared to 138 healthy controls. Analysis identified a cytokine/chemokine signature that diagnosed XMRV-associated CFS with 93% specificity and 96% sensitivity. This signature provides immunological evidence for the role of XMRV in CFS pathology and the associated inflammatory response.
Human T-Cell Leukemia Virus Type 1 (HTLV-1) is a retrovirus that causes leukemia by interfering with tumor suppressor genes. It was the first human retrovirus discovered. HTLV-1 infects T-cells and causes cancer by changing the action of the TP53 tumor suppressor gene, leading to uncontrolled cell growth. The virus can also cause a severe form of leukemia called Adult T-Cell Leukemia. Additionally, HTLV-1 weakens the immune system by decreasing T-lymphocyte numbers, making the body vulnerable to other diseases.
Natural history of human papillomavirus infections, cytologic and histologic ...Eliana Cordero
This document summarizes the natural history of human papillomavirus (HPV) infections and their relationship to abnormal cervical cytology and histology. It discusses that most HPV infections are transient and asymptomatic, but persistent infection with high-risk HPV types can sometimes lead to precancerous lesions and cervical cancer over many years. HPV type 16 is the most common high-risk type associated with cervical cancer. Screening programs have reduced cervical cancer rates in many countries, but it remains a health issue.
Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AI...Dr. Juan Rodriguez-Tafur
This document analyzes the association between MHC ancestral haplotypes and rates of progression to AIDS. It finds that the 8.1 and 44.2 ancestral haplotypes are associated with rapid progression to AIDS, while the 35.2 and 57.1 haplotypes are associated with slow progression. Analysis of recombinant fragments of these haplotypes identifies MHC regions within the 35.1, 35.2, and 44.2 haplotypes associated with rapid progression, and within the 44.1 and 57.1 haplotypes associated with slow progression. Previous studies identified single HLA alleles associated with progression; this study confirms the direct role of HLA-B35 in rapid progression through haplotype analysis.
Human genetic variation can influence treatment prognosis for hepatitis C virus (HCV). A single nucleotide polymorphism near the IFNL3 gene indicates natural resistance to type 1 HCV, with the T variant associated with poorer treatment outcomes. Additionally, a polymorphism in the interleukin-23 receptor gene correlates with reduced risk of HCV-related liver cancer. HCV appears to have evolved to benefit from allelic variations between geographic regions. Future treatment may focus on precise virus-genome interactions. Mapping the entire human genome could increase understanding of connections between HCV and its human host.
This study estimates the effective recombination rate and distribution of selection coefficients in HIV using time series sequence data from infected patients. By examining how new haplotype combinations arise between time points, the researchers estimated an effective recombination rate of 1.460.661025 recombinations per site and generation. They also found evidence that at least 15% of observed non-synonymous mutations are selected for at a rate exceeding 0.8% per generation. This provides quantitative parameters for understanding HIV evolution within patients over time.
This document compares the allele frequencies of 15 Plasmodium falciparum merozoite antigen genes in malaria infections sampled in Kenya in 2007 and 2008. It finds fluctuating allele frequencies in codons 147 and 148 of the reticulocyte-binding homologue 5 (Rh5) gene over this period in uncomplicated malaria infections. However, the dominant YH haplotype was stable over multiple years in asymptomatic and complicated infections. A regression analysis found the chance of the less common HD haplotype decreased over time from 2007 to 2009 in uncomplicated and asymptomatic infections.
Viruses can cause cancer through several mechanisms. Small DNA tumor viruses like HPV and adenovirus often integrate into the host genome and express early genes that promote cell cycle progression and prevent apoptosis. This leads to uncontrolled cell growth. Herpesviruses like EBV and KSHV can cause cancer during their latency phase by expressing genes that induce cell activation and proliferation programs. Chronic viral infections may also cause cancer over long periods through prolonged inflammation. Studying virus-associated cancers provides insights into cancer mechanisms and potential new targets for treatment.
Lombardi et al: XMRV/CFS Inflammatory Signaturedegarden
This document summarizes a study that identified a signature of 10 cytokines and chemokines that can correctly identify patients with chronic fatigue syndrome (CFS) associated with xenotropic murine leukemia virus-related virus (XMRV) infection. The study used Luminex multi-analyte profiling to measure cytokine and chemokine levels in the plasma of 118 CFS patients who tested positive for XMRV, compared to 138 healthy controls. Analysis identified a cytokine/chemokine signature that diagnosed XMRV-associated CFS with 93% specificity and 96% sensitivity. This signature provides immunological evidence for the role of XMRV in CFS pathology and the associated inflammatory response.
Human T-Cell Leukemia Virus Type 1 (HTLV-1) is a retrovirus that causes leukemia by interfering with tumor suppressor genes. It was the first human retrovirus discovered. HTLV-1 infects T-cells and causes cancer by changing the action of the TP53 tumor suppressor gene, leading to uncontrolled cell growth. The virus can also cause a severe form of leukemia called Adult T-Cell Leukemia. Additionally, HTLV-1 weakens the immune system by decreasing T-lymphocyte numbers, making the body vulnerable to other diseases.
Plasma levels of circulating nucleic acids (CNAs) were significantly higher in patients with Plasmodium vivax malaria compared to healthy donors. CNAs levels strongly correlated with clinical markers of malaria morbidity, including fever and thrombocytopenia. Higher CNAs levels were also associated with a more severe clinical presentation based on a scoring system. These findings suggest that CNAs have potential as sensitive biomarkers for assessing severity of P. vivax malaria infections.
Prevalence of XMRV Nucleic Acid and Antibody in HIV-1 Infected Men and in Men...degarden
This study assessed the prevalence of XMRV infection in 332 men from the Multicenter AIDS Cohort Study (MACS) using multiple diagnostic methods. Plasma samples were screened for XMRV antibodies and those with positive results were further tested along with matched negative controls for XMRV RNA and DNA. While 9 samples showed low positive reactivity to XMRV proteins by chemiluminescent immunoassay, none were positive for XMRV RNA or DNA. The study found no evidence of active XMRV infection in the MACS cohort regardless of HIV status.
This document reviews oncogenic, or cancer-causing, viruses. It aims to highlight the distribution and epidemiology of viruses associated with cancer. Several viruses are known to or suspected of causing cancer in humans, including human papillomavirus, Epstein-Barr virus, hepatitis B and C viruses, human herpesvirus 8, human immunodeficiency virus, and human T-lymphotropic virus 1. Oncogenic viruses are divided into DNA and RNA viruses. They cause cancer through various mechanisms during viral replication, including activating oncogenes and causing mutations. The prevalence of viral infections worldwide that are associated with cancer varies by virus and region. Certain virus-induced cancers also have high rates globally, such
This study examined risk factors for HCV infection and severity of liver disease in 86 Mexican women reactive for anti-HCV antibodies. Surgery (80%) and blood transfusions before 1993 (58%) were main risk factors, with 52% having both. The most common reasons for surgery and transfusion were obstetric/gynecologic (74% and 68%). 64% were HCV RNA positive. Age and history of transfusion before 1993 predicted cirrhosis. Anti-HCV levels correlated with time since transfusion but not age. HBV co-infection rate was low (5%) and did not influence severity.
Oncogenic viruses can interact with host cells in ways that promote oncogenesis through both direct and indirect mechanisms. Direct mechanisms include viruses introducing oncogenes that alter cellular signaling pathways and disrupt cell cycle control. Indirect mechanisms involve evading immune responses, establishing chronic infections, and inducing chronic inflammation. Specific oncogenic viruses discussed include EBV, HPV, HBV, HCV, HTLV-1, and KSHV. Each virus employs distinct strategies to activate cancer hallmarks in host cells, with EBV and HPV expressing oncoproteins that mimic cellular signaling and proliferation factors, while HBV/HCV cause liver damage and HBV/HTLV-1 inhibit apoptosis.
1) The study analyzed HIV-1 sequences from 37 patients with high numbers (34 or more) of degenerate base codes in their protease/reverse transcriptase sequences, which can indicate either extensive viral evolution or dual infection. 2) Phylogenetic analysis of envelope and gag sequences from these patients found that 16 (43%) had dual HIV-1 infections, representing 1% of all sequences analyzed. 3) Patients with the highest numbers of degenerate base codes were more likely to have dual infections with different HIV-1 subtypes. The study demonstrates that routine HIV genotyping can help detect undiagnosed dual infections.
Oncogenic viruses are viruses that can cause cancer. They do so by inserting their DNA into host cells and altering gene expression in ways that promote uncontrolled cell growth and division. Some key points:
- Viruses like HPV, EBV, HBV can lay dormant in the body for years before causing tumors by disrupting tumor suppressor genes or activating oncogenes.
- Oncogenic viruses establish persistent infections to evade the immune system and immunosuppression increases cancer risk.
- Viral oncogenes are incorporated into host cell DNA and cause overexpression of cellular genes involved in growth regulation.
- Cancers linked to oncogenic viruses include cervical cancer from HPV, lymphomas
1) The document proposes an alternative theory that SV40 and other DNA tumor viruses cause cancer indirectly by inducing aneuploidy (an abnormal number of chromosomes), rather than directly through viral oncoproteins.
2) Aneuploidy destabilizes the genome and catalyzes random karyotypic and gene expression changes, eventually generating rare cell lineages with self-sufficient growth (cancer).
3) This explains characteristics of viral carcinogenesis like the low probability of cancer development, individual cancers phenotypes, and recurrence without viral proteins.
This document discusses viruses associated with lymphoma. It focuses on Epstein-Barr virus (EBV) which is present in tumor cells of some lymphomas. EBV infects B cells and can immortalize them in vitro, expressing genes that drive proliferation. While EBV infection is common, only a small subset develops lymphoma, showing lymphomagenesis requires additional factors. EBV is strongly associated with several lymphoma subtypes, variably associated with others, and rarely associated with some. Post-transplant lymphoproliferative disorder is often EBV-associated due to immunosuppression allowing infected B cells to proliferate.
This document discusses challenges and opportunities for developing an AIDS vaccine. It describes several key difficulties, including HIV's sequence diversity, ability to infect immune cells, and mechanisms for immune avoidance. The document also reviews past vaccine trial results and discusses various vaccine design approaches, including those aimed at eliciting cytotoxic T-lymphocytes, antibodies, or using viral vectors. Developing an effective AIDS vaccine will likely require a multi-disciplinary approach and stimulation of multiple arms of the immune system.
This study evaluated the frequency of asymptomatic Plasmodium carriers (APCs) among blood donors in four blood banks in the Brazilian Amazon region. Blood samples from 400 donors who passed screening were tested using PCR to detect Plasmodium DNA. The positivity rate varied from 1-3% between blood banks, with an overall rate of 2.3%. All positive samples contained mixed infections of P. vivax and P. falciparum. While screening methods used by the blood banks did not detect the infections, PCR revealed its superiority for detecting low levels of parasites. The results emphasize the need to improve screening for APCs in blood banks in malaria endemic areas to control transfusion-transmitted malaria.
Journal Reading Stem Cell dengan HIV (sharon) soroylardo1
1) Studies in murine and macaque models show that genetically modifying CD4+ T-cells to disrupt CCR5, the main HIV coreceptor, provides a selective advantage over non-modified cells and significantly reduces plasma viremia. However, a source of residual viral reservoir remains.
2) Two HIV patients who underwent allogeneic stem cell transplantation from CCR5-negative donors have remained virus-free for nearly 4 years after transplantation while kept on antiretroviral therapy (ART), suggesting genetic modification may not be necessary if ART is completely suppressive.
3) Hematopoietic stem cell transplantation remains a promising curative approach for HIV, but the timing of ART interruption
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
This study investigated the relationship between variants of the glycophorin B (GPB) gene and susceptibility to Plasmodium falciparum infection in the Brazilian Amazon. The researchers found that individuals carrying the GYPB*S allele were more likely to be infected with P. falciparum than those without this allele. Sequence analysis of GYPB also suggested it has been under natural selection due to malaria. This study provides evidence that genetic variation in GPB receptor influences the ability of P. falciparum to invade red blood cells in this population.
This document summarizes a review article on the genetic, autoimmune, and environmental factors involved in rheumatoid arthritis (RA). It discusses how RA results from an interplay between these factors. Genetically, the HLA-DRB1 gene is a major determinant of RA risk. Over 30 non-MHC genes have also been associated with RA through genome-wide association studies and studies of specific populations, including STAT4, PADI4, and PTPN22. Environmental risks like smoking may interact with genetic susceptibility to increase RA risk. Understanding the roles of disease-associated genes and gene-environment interactions could lead to improved RA treatments and prevention strategies.
Pak Us Science And Technology Grant Project E Ditedabbas491
This document outlines a proposed collaborative project between researchers at NUST in Pakistan and UCSD in the US to study Hepatitis B virus (HBV) genotypes and their association with Hepatocellular Carcinoma (HCC) in Pakistan. The objectives are to characterize HBV genotypes, identify virus mutations that increase risk of HCC, and study the role of cellular editing enzymes and HBx protein. The project will involve sample collection from hospitals, genotyping, sequencing, and in vitro studies over 3 years. The researchers have facilities and expertise to conduct molecular and clinical analyses of HBV in Pakistan where genotype D is prevalent and HBV infection is a major health problem.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
NORMES INTERNATIONALES SUR LA TRANSPARENCE ET LA RESPONSABILISATIONJamaity
Produit en collaboration avec le Centre pour le droit et la démocratie, ce document d'information se fonde sur deux sources de droit mous et durs pour illustrer les fondements du droit international en matière de transparence et de responsabilité.
Interior architects specialize in designing interior spaces for homes and commercial buildings. They draft plans that consider safety, functionality, aesthetics, and clients' tastes while complying with relevant regulations. Interior architects are involved throughout construction and renovation projects, initially consulting with clients to understand needs and later producing design plans using software.
Plasma levels of circulating nucleic acids (CNAs) were significantly higher in patients with Plasmodium vivax malaria compared to healthy donors. CNAs levels strongly correlated with clinical markers of malaria morbidity, including fever and thrombocytopenia. Higher CNAs levels were also associated with a more severe clinical presentation based on a scoring system. These findings suggest that CNAs have potential as sensitive biomarkers for assessing severity of P. vivax malaria infections.
Prevalence of XMRV Nucleic Acid and Antibody in HIV-1 Infected Men and in Men...degarden
This study assessed the prevalence of XMRV infection in 332 men from the Multicenter AIDS Cohort Study (MACS) using multiple diagnostic methods. Plasma samples were screened for XMRV antibodies and those with positive results were further tested along with matched negative controls for XMRV RNA and DNA. While 9 samples showed low positive reactivity to XMRV proteins by chemiluminescent immunoassay, none were positive for XMRV RNA or DNA. The study found no evidence of active XMRV infection in the MACS cohort regardless of HIV status.
This document reviews oncogenic, or cancer-causing, viruses. It aims to highlight the distribution and epidemiology of viruses associated with cancer. Several viruses are known to or suspected of causing cancer in humans, including human papillomavirus, Epstein-Barr virus, hepatitis B and C viruses, human herpesvirus 8, human immunodeficiency virus, and human T-lymphotropic virus 1. Oncogenic viruses are divided into DNA and RNA viruses. They cause cancer through various mechanisms during viral replication, including activating oncogenes and causing mutations. The prevalence of viral infections worldwide that are associated with cancer varies by virus and region. Certain virus-induced cancers also have high rates globally, such
This study examined risk factors for HCV infection and severity of liver disease in 86 Mexican women reactive for anti-HCV antibodies. Surgery (80%) and blood transfusions before 1993 (58%) were main risk factors, with 52% having both. The most common reasons for surgery and transfusion were obstetric/gynecologic (74% and 68%). 64% were HCV RNA positive. Age and history of transfusion before 1993 predicted cirrhosis. Anti-HCV levels correlated with time since transfusion but not age. HBV co-infection rate was low (5%) and did not influence severity.
Oncogenic viruses can interact with host cells in ways that promote oncogenesis through both direct and indirect mechanisms. Direct mechanisms include viruses introducing oncogenes that alter cellular signaling pathways and disrupt cell cycle control. Indirect mechanisms involve evading immune responses, establishing chronic infections, and inducing chronic inflammation. Specific oncogenic viruses discussed include EBV, HPV, HBV, HCV, HTLV-1, and KSHV. Each virus employs distinct strategies to activate cancer hallmarks in host cells, with EBV and HPV expressing oncoproteins that mimic cellular signaling and proliferation factors, while HBV/HCV cause liver damage and HBV/HTLV-1 inhibit apoptosis.
1) The study analyzed HIV-1 sequences from 37 patients with high numbers (34 or more) of degenerate base codes in their protease/reverse transcriptase sequences, which can indicate either extensive viral evolution or dual infection. 2) Phylogenetic analysis of envelope and gag sequences from these patients found that 16 (43%) had dual HIV-1 infections, representing 1% of all sequences analyzed. 3) Patients with the highest numbers of degenerate base codes were more likely to have dual infections with different HIV-1 subtypes. The study demonstrates that routine HIV genotyping can help detect undiagnosed dual infections.
Oncogenic viruses are viruses that can cause cancer. They do so by inserting their DNA into host cells and altering gene expression in ways that promote uncontrolled cell growth and division. Some key points:
- Viruses like HPV, EBV, HBV can lay dormant in the body for years before causing tumors by disrupting tumor suppressor genes or activating oncogenes.
- Oncogenic viruses establish persistent infections to evade the immune system and immunosuppression increases cancer risk.
- Viral oncogenes are incorporated into host cell DNA and cause overexpression of cellular genes involved in growth regulation.
- Cancers linked to oncogenic viruses include cervical cancer from HPV, lymphomas
1) The document proposes an alternative theory that SV40 and other DNA tumor viruses cause cancer indirectly by inducing aneuploidy (an abnormal number of chromosomes), rather than directly through viral oncoproteins.
2) Aneuploidy destabilizes the genome and catalyzes random karyotypic and gene expression changes, eventually generating rare cell lineages with self-sufficient growth (cancer).
3) This explains characteristics of viral carcinogenesis like the low probability of cancer development, individual cancers phenotypes, and recurrence without viral proteins.
This document discusses viruses associated with lymphoma. It focuses on Epstein-Barr virus (EBV) which is present in tumor cells of some lymphomas. EBV infects B cells and can immortalize them in vitro, expressing genes that drive proliferation. While EBV infection is common, only a small subset develops lymphoma, showing lymphomagenesis requires additional factors. EBV is strongly associated with several lymphoma subtypes, variably associated with others, and rarely associated with some. Post-transplant lymphoproliferative disorder is often EBV-associated due to immunosuppression allowing infected B cells to proliferate.
This document discusses challenges and opportunities for developing an AIDS vaccine. It describes several key difficulties, including HIV's sequence diversity, ability to infect immune cells, and mechanisms for immune avoidance. The document also reviews past vaccine trial results and discusses various vaccine design approaches, including those aimed at eliciting cytotoxic T-lymphocytes, antibodies, or using viral vectors. Developing an effective AIDS vaccine will likely require a multi-disciplinary approach and stimulation of multiple arms of the immune system.
This study evaluated the frequency of asymptomatic Plasmodium carriers (APCs) among blood donors in four blood banks in the Brazilian Amazon region. Blood samples from 400 donors who passed screening were tested using PCR to detect Plasmodium DNA. The positivity rate varied from 1-3% between blood banks, with an overall rate of 2.3%. All positive samples contained mixed infections of P. vivax and P. falciparum. While screening methods used by the blood banks did not detect the infections, PCR revealed its superiority for detecting low levels of parasites. The results emphasize the need to improve screening for APCs in blood banks in malaria endemic areas to control transfusion-transmitted malaria.
Journal Reading Stem Cell dengan HIV (sharon) soroylardo1
1) Studies in murine and macaque models show that genetically modifying CD4+ T-cells to disrupt CCR5, the main HIV coreceptor, provides a selective advantage over non-modified cells and significantly reduces plasma viremia. However, a source of residual viral reservoir remains.
2) Two HIV patients who underwent allogeneic stem cell transplantation from CCR5-negative donors have remained virus-free for nearly 4 years after transplantation while kept on antiretroviral therapy (ART), suggesting genetic modification may not be necessary if ART is completely suppressive.
3) Hematopoietic stem cell transplantation remains a promising curative approach for HIV, but the timing of ART interruption
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
This study investigated the relationship between variants of the glycophorin B (GPB) gene and susceptibility to Plasmodium falciparum infection in the Brazilian Amazon. The researchers found that individuals carrying the GYPB*S allele were more likely to be infected with P. falciparum than those without this allele. Sequence analysis of GYPB also suggested it has been under natural selection due to malaria. This study provides evidence that genetic variation in GPB receptor influences the ability of P. falciparum to invade red blood cells in this population.
This document summarizes a review article on the genetic, autoimmune, and environmental factors involved in rheumatoid arthritis (RA). It discusses how RA results from an interplay between these factors. Genetically, the HLA-DRB1 gene is a major determinant of RA risk. Over 30 non-MHC genes have also been associated with RA through genome-wide association studies and studies of specific populations, including STAT4, PADI4, and PTPN22. Environmental risks like smoking may interact with genetic susceptibility to increase RA risk. Understanding the roles of disease-associated genes and gene-environment interactions could lead to improved RA treatments and prevention strategies.
Pak Us Science And Technology Grant Project E Ditedabbas491
This document outlines a proposed collaborative project between researchers at NUST in Pakistan and UCSD in the US to study Hepatitis B virus (HBV) genotypes and their association with Hepatocellular Carcinoma (HCC) in Pakistan. The objectives are to characterize HBV genotypes, identify virus mutations that increase risk of HCC, and study the role of cellular editing enzymes and HBx protein. The project will involve sample collection from hospitals, genotyping, sequencing, and in vitro studies over 3 years. The researchers have facilities and expertise to conduct molecular and clinical analyses of HBV in Pakistan where genotype D is prevalent and HBV infection is a major health problem.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
NORMES INTERNATIONALES SUR LA TRANSPARENCE ET LA RESPONSABILISATIONJamaity
Produit en collaboration avec le Centre pour le droit et la démocratie, ce document d'information se fonde sur deux sources de droit mous et durs pour illustrer les fondements du droit international en matière de transparence et de responsabilité.
Interior architects specialize in designing interior spaces for homes and commercial buildings. They draft plans that consider safety, functionality, aesthetics, and clients' tastes while complying with relevant regulations. Interior architects are involved throughout construction and renovation projects, initially consulting with clients to understand needs and later producing design plans using software.
Zindzi Fire Engineering is committed to transparency and accountability. To ensure high standards, they maintain accreditations from several organizations including the South African Bureau of Standards, the Private Security Industry Regulatory Authority, the Fire Fighting Equipment Traders Association, the South African Qualification & Certification Committee, and the Institute of Fire Engineers. They also comply with ISO 9001:2000 standards and SANS regulations for fire protection equipment.
The document discusses a model for controlled variation that allows organizations to adapt to changing markets. It proposes that mature governance systems can maintain control over natural variation within their structures to remain competitive. Knowledge is an organizational asset that can be made "fungible" or transferable through processes that assign it value. An emerging paradigm views organizations as dynamic and evolving through controlled experimentation, in contrast to relying only on existing expertise. This balanced approach to risk management through governance supports innovation while focusing on enhancing brand value and market share.
A FRAMEWORK FOR SUMMARIZATION OF ONLINE OPINION USING WEIGHTING SCHEMEaciijournal
Recently there is wide use of social media includes various opinion sites, complaints sites, government
sites, question-answering sites, etc. through which customer get services, opinion, information, etc. but
because of this there is more and more use of these social media right now so huge amount of data will be
created, from this huge data people get confused while taking any decision about particular problem or
services. For example, customer wants to purchase a product at that time he/she want the previous
customer feedback or opinion about that product. But if there is lots of opinion available for particular
product then that customer get confused while taking decision whether purchase that product or not. In this
case there is a need of summarization concept means that only show the short and concise manner
summary about service or product so that customer or organization easily understand and able to take
right decision fast. Our proposed framework creating such summary which contain three main phases or
steps. Firstly preprocessing is done in that stop words are removed and stemming is performed. In second
phase identify frequent features using two techniques weight constraint and association rule and at the last
phase it find semantics and generate the summary so that customer will able to take step without confusion.
No matter how big or small the business, seo is now an integral part of almost every marketing strategy. Although many small business owners choose to do their own SEO, there will come a point when it's time to consider outsourcing, and there are many good reasons. For details visit
http://www.tr3sadvertising.com/
This document is the Traffic Act of Kenya. It contains 12 parts that cover various aspects of traffic laws in Kenya. Some key points:
- It establishes the roles and powers of traffic officers, inspectors, and examiners to enforce traffic laws.
- It requires the registration and licensing of vehicles, and sets fees and processes for obtaining licenses.
- It requires drivers to obtain driving licenses, setting the criteria and processes for licenses.
- It establishes offenses related to reckless driving, speeding, driving under the influence, and other unsafe driving behaviors.
- It gives powers to regulate traffic through signs, road closures, and designating parking areas.
- It covers accidents and
Ilmuwan sosial Indonesia terkenal mengutip hadits Nabi Muhammad SAW tentang kebaikan dan keburukan. Hadits tersebut menekankan pentingnya menghindari keburukan dan melakukan kebaikan.
Primary effusion lymphoma (formerly known as body cavity lymphoma), is an infrequent, aggressive B cell non-Hodgkin’s lym-phoma. The human herpes virus 8 (HHV8) or the Kaposi’s sarcoma associated herpes virus (KSHV) may be the potential determinant of the malignancy [1].
Martin Chang, MBBE final report, 2012_08_21Martin Chang
This document summarizes key information about developing an effective blood-stage malaria vaccine, including:
1) Existing vaccines like RTS,S have shown only partial effectiveness, so more effective vaccines are still needed.
2) The malaria parasite has different life stages, and vaccines target different stages. This report focuses on blood-stage vaccines.
3) Effective immune mechanisms against blood-stage parasites include antibody-dependent cellular inhibition (ADCI) and antibody-dependent respiratory burst (ADRB), but these have not been fully induced by existing vaccines.
This study aims to discover potential white blood cell surface biomarkers that could predict which patients presenting to the emergency department with suspected sepsis will develop severe sepsis. The study will prospectively collect data from three patient populations - 300 patients with suspected sepsis in the emergency department, 100 critically ill patients with established sepsis in the ICU, and 100 non-septic control patients in the emergency department. White blood cell surface markers will be analyzed using flow cytometry. Candidate biomarkers will be selected by comparing markers between cohorts, and their predictive value for clinical outcomes will be explored within the suspected sepsis emergency department cohort. The goal is to identify biomarkers that could help predict deterioration early to guide triage, treatment and monitoring.
The Prevalence of Cytomegalovirus among Eligible Blood Donors in Keffi, NigeriaConferenceproceedings
8th International Scientific Conference on Applied
Sciences and Engineering
2-3 April, 2016
Hotel Istana Kuala Lumpur City Centre, Kuala Lumpur, Malaysia
This document summarizes a study examining the role of CD44 variant 9 (CD44v9) and Muc18 expression in prostate cancer invasion and metastasis. The study found that prostate cancer tissues and metastases overexpressed CD44v7-v10 isoforms compared to benign tissue. Silencing CD44v9 expression in cultured prostate cancer cells significantly reduced invasiveness into Matrigel, while silencing Muc18 had a smaller effect. A more invasive cell line, Gsa, was also found to overexpress CD44v9. The results suggest that prostate cancer invasion is more influenced by CD44v9 expression than by Muc18 expression.
Post-transplant lymphoproliferative disorder (PTLD) is a B-cell proliferation disorder caused by Epstein-Barr virus infection due to immunosuppression after organ transplantation. The risk of PTLD is higher with more intense immunosuppression and occurs earlier. Treatment involves reducing immunosuppression to allow the immune system to control the proliferation. PTLD ranges from benign B-cell hyperplasia to aggressive lymphoma and has high mortality if not treated by reducing immunosuppression.
This document describes a study that analyzed the frequency of cells with a PIG-A mutant phenotype (PNH phenotype) in samples from 19 patients with acute lymphoblastic leukemia (ALL) and immortalized B cell lines (BLCLs) from healthy donors. The BLCLs showed a median frequency of 11 x 10-6, while the ALL samples showed two distinct populations - about half of samples had a median frequency of 13 x 10-6, similar to controls, while the other half had a significantly higher median frequency of 566 x 10-6. This suggests that in ALL, there are two phenotypes with respect to hypermutability, which may correlate with the number of mutations required to cause the leukemia.
Lenalidomide inhibits the proliferation of chronic lymphocytic leukemia (CLL) cells through a mechanism dependent on cereblon and p21, but independent of p53. Treatment with lenalidomide upregulates the expression of the cyclin-dependent kinase inhibitor p21 in CLL cells, leading to inhibition of proliferation. Silencing of either cereblon or p21 impairs the ability of lenalidomide to inhibit CLL cell proliferation. Lenalidomide also induces p21 expression in CLL cells isolated from patients, indicating it can directly inhibit CLL cell proliferation through cereblon and p21 in vivo.
This document provides information about malaria vaccines. It discusses the context of malaria globally and the need for a vaccine. Several potential vaccine candidates target different stages of the malaria parasite's lifecycle, including sporozoites, infected hepatocytes, and erythrocytic stages. Developing an effective vaccine is challenging due to the parasite's diversity and complexity. The most promising current candidate is RTS,S, which provides some protection against malaria in clinical trials but is not fully effective.
This document summarizes information about malaria vaccines. It discusses how malaria is caused by Plasmodium parasites and transmitted by mosquitoes. Four species can infect humans. Current vaccines target different stages of the parasite's life cycle, including pre-erythrocytic, blood, and sexual stages. Challenges to vaccine development include the parasite's ability to evade the immune system through antigenic variation. Several candidate vaccines are discussed that target different stages, but none have achieved high levels of efficacy and durability.
This study investigated whether changes in complement regulatory proteins (CD55 and CD59) on red blood cells contributes to malaria-induced anemia. The study found:
1) Levels of CD55 and CD59 decreased with increased red blood cell age.
2) CD55 levels were lower in children with malaria-induced anemia compared to non-anemic children, and this difference was seen across all red blood cell age groups.
3) CD55 levels correlated positively with hemoglobin levels in anemic children, but CD59 levels did not.
4) The extensive and early loss of CD55 from red blood cells of all ages in malaria-induced anemia, as well as
Post-transplant lymphoproliferative disorder/disease (PTLD) is a B-cell proliferation disorder following infection with EpsteineBarr virus due to therapeutic immunosuppression after organ transplantation. The more intense the immunosuppression, the higher the incidence of PTLD and the earlier it occurs. The cornerstone of successful treatment of PTLD is reduction or withdrawal of immunosuppression.
This study investigated an outbreak of neonatal sepsis in a neonatal intensive care unit attributed to coagulase-negative staphylococci (CoNS). The aims were to assess the association between intravenous catheters and CoNS sepsis, identify persistent CoNS strains, and determine antibiotic resistance patterns. Random amplified polymorphic DNA (RAPD) analysis identified two main clusters of CoNS isolates, with some strains showing similarity over 88%, suggesting persistence. Staphylococcus capitis was the most prevalent pathogen, infecting 80% of patients and showing multi-drug resistance. The results support that CoNS are a significant cause of neonatal intensive care unit sepsis, can infect via intravenous catheters, and persistent strains may cir
1) The study examined samples of benign oral squamous cell carcinoma (BOSC) and oral squamous cell carcinoma (OSCC) to determine the incidence of HPV infection and mutations in p53 and c-myc genes.
2) It found that 23% of BOSC samples and 73% of OSCC samples had HPV infections. All BOSC samples with HPV infection showed no mutations in p53 or c-myc genes, while 81% of OSCC samples with HPV infection had no p53 mutation and 91% had no c-myc mutation.
3) Statistical analysis revealed significant differences between BOSC and OSCC groups in terms of HPV infection without mutations in p53 and
1) The study aimed to use the PP65 antigenemia technique to diagnose active cytomegalovirus (CMV) infection in AIDS patients in Brazil and examine its occurrence in the region.
2) They found that 14 of 50 AIDS patients tested positive for PP65 antigenemia, indicating active CMV infection, while none of the 34 bone marrow transplant patients tested positive.
3) Having a CD4+ T-cell count below 100 cells/mm3 appeared to increase the risk of testing positive for PP65 antigenemia and active CMV infection, as more low CD4 count patients tested positive compared to higher CD4 count patients.
This article summarizes a study of 785 Tanzanian children living in an area with intense malaria transmission. The study found that iron deficiency (ID), as measured by ferritin levels in blood samples taken at routine visits, significantly decreased the odds of subsequent malaria parasitemia, severe malaria, and all-cause mortality in children. When samples from sick visits were also included, ID was associated with significantly lower prevalence of parasitemia, hyperparasitemia (very high parasite levels), and severe malaria at the time of sample collection. The results suggest that naturally occurring ID protects against severe malaria and death in young children, and that iron supplementation may increase malaria risk even in children with ID. Future studies are needed to determine
This study examined the relationship between iron deficiency and malaria risk in 785 Tanzanian children from birth to 3 years of age. The key findings were:
1. Iron deficiency was found to be protective against malaria, with children who had iron deficiency having lower odds of parasitemia, hyperparasitemia, severe malaria, and all-cause mortality compared to children who were iron-replete.
2. Iron deficiency was associated with a 6.6-fold lower odds of concurrent parasitemia and a 24.0-fold lower odds of concurrent hyperparasitemia. It also reduced the odds of severe malaria by 4.0-fold.
3. Prospective analyses found that iron deficiency
Mutations of oncogenes or inhibitors of oncogenes can lead to
the emergence of isolated dormant malignant tumor cells, but only rare are sufficient for inducing an active malignant tumor growth, i.e., for appearance cancer as illness. Will or will not occur the active growth of malignant tumor depends in essence on the condition of reparative-regenerative systems of a particular organ and the whole organism
Chronic Hepatitis C Virus Infection and Carcinoma Cervix – Report of a Case ...Apollo Hospitals
We report a case of a 54 year old woman with carcinoma cervix and chronic hepatitic C infection. Hepatitis C Virus was isolated from the malignant cervical tissue which caused Chronic Hepatitis and may have had a direct role in the development and pathogenesis of cervical cancer.
This document discusses disseminated intravascular coagulation (CID), providing definitions, pathophysiology, risk factors, signs and symptoms, treatment options, and examples of research articles on the topic. Specifically, it defines CID as an alteration in coagulation factor V and VII that results in the excessive production of small blood clots within blood vessels. This causes thrombi to form in small blood vessels throughout the peripheral parts of the body. Risk factors include bacteria, viruses, and congenital factors. Signs may include purpura, microangiopathy, and cardiac congestion. Treatment involves blood transfusions, anticoagulants, and plasmapheresis. Examples of relevant research articles are also provided.
1. CD47 regulates the phagocytic clearance and
replication of the Plasmodium yoelii malaria parasite
Rajdeep Banerjeea
, Sanjay Khandelwalb
, Yukiko Kozakaia
, Bikash Sahua
, and Sanjai Kumara,1
a
Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics
Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993; and b
Department of Medicine, Duke University Medical Center, Durham,
NC 27710
Edited by Louis H. Miller, National Institutes of Health, Rockville, MD, and approved January 28, 2015 (received for review September 19, 2014)
Several Plasmodium species exhibit a strong age-based preference
for the red blood cells (RBC) they infect, which in turn is a major
determinant of disease severity and pathogenesis. The molecular
basis underlying this age constraint on the use of RBC and its in-
fluence on parasite burden is poorly understood. CD47 is a marker
of self on most cells, including RBC, which, in conjunction with
signal regulatory protein alpha (expressed on macrophages), pre-
vents the clearance of cells by the immune system. In this report,
we have investigated the role of CD47 on the growth and survival
of nonlethal Plasmodium yoelii 17XNL (PyNL) malaria in C57BL/6
mice. By using a quantitative biotin-labeling procedure and a GFP-
expressing parasite, we demonstrate that PyNL parasites prefer-
entially infect high levels of CD47 (CD47hi
)-expressing young RBC.
Importantly, C57BL/6 CD47−/−
mice were highly resistant to PyNL
infection and developed a 9.3-fold lower peak parasitemia than
their wild-type (WT) counterparts. The enhanced resistance to
malaria observed in CD47−/−
mice was associated with a higher
percentage of splenic F4/80+
cells, and these cells had a higher
percentage of phagocytized parasitized RBC than infected WT
mice during the acute phase of infection, when parasitemia was
rapidly rising. Furthermore, injection of CD47-neutralizing anti-
body caused a significant reduction in parasite burden in WT
C57BL/6 mice. Together, these results strongly suggest that
CD47hi
young RBC may provide a shield to the malaria parasite
from clearance by the phagocytic cells, which may be an immune
escape mechanism used by Plasmodium parasites that preferen-
tially infect young RBC.
malaria | Plasmodium yoelii | RBC | CD47 | F4/80
Malaria, caused by Plasmodium parasites, remains a major
cause of mortality and morbidity in the developing world.
Among the four principal human Plasmodium species, Plasmo-
dium falciparum is the most virulent, being responsible for more
than 90% of malaria-associated deaths. Likewise, Plasmodium
species that infect rodents and nonhuman primates also differ
widely in their fulminant nature and in the mortality they cause
(1–3). How different Plasmodium species have evolved to exhibit
this wide array of virulence and disease severity remains one of the
major unsolved questions in malaria biology and pathogenesis.
One important factor that is associated with Plasmodium
parasite burden and disease severity is the age constraint of the
host red blood cells (RBC) they infect. The age-based preference
for restricted invasion of RBC by the Plasmodium parasite is
characterized as young RBC (reticulocyte), aged RBC (mature),
or both young and aged RBC. Plasmodium species that prefer-
entially infect and grow inside young RBC generally cause a low-
grade, self-resolving infection that is rarely fatal (e.g., Plasmodium
vivax and Plasmodium ovale), whereas those that infect both young
and aged RBC cause more fulminant infection that can be fatal in
the absence of immunity (e.g., P. falciparum) (1, 4–6). Thus, along
with host genetic background and immune response, restriction
for age-specific RBC invasion is a major determinant of the
severity and outcome of malaria infection.
Malaria parasites have evolved to use redundant receptors and
pathways to invade the RBC. For example, sialic acid (7) and
Duffy antigen (8) are the major RBC receptors for invasion of
P. falciparum and P. vivax, respectively, although other receptors
and invasion pathways are known to exist (9, 10). Although
a redundancy in RBC receptor use would ensure successful in-
vasion by mitigating the effects of polymorphism and immune
targeting, the reasons behind the RBC age-based preference for
invasion are not fully clear and remain a subject of debate.
Survival of normal cells through the course of their life cycle is
essential to maintain homeostasis, and aberrant cells (e.g., senes-
cent or foreign antigen-expressing cells) are eliminated through
a sophisticated programmed cell removal system that relies on the
recognition of self and nonself determinants (11). CD47, a cell
surface molecule in the Ig superfamily, is ubiquitously expressed
on many cell types, including RBC, and is a marker of self to avoid
early clearance by phagocytic cells through ligation of signal
regulatory protein alpha (12). In contrast, altered expression or
conformational changes in CD47 may lead to a molecular switch
that triggers a phagocytic signal to remove aged or damaged cells
(11). Recent studies have shown that the level of CD47 expres-
sion is higher in progenitor cells and declines as they undergo
maturation and are subsequently aged (13). This age-dependent
difference in CD47 expression shields young cells but allows
clearance of aging and damaged cells from the system.
CD47 is overexpressed in cancer cells (11, 14, 15), and the
CD47–signal regulatory protein alpha interaction is considered
a major pathway of immune evasion by tumor cells (15). Ad-
ministration of anti-CD47 antibodies enabled the phagocytosis
Significance
Several Plasmodium species exhibit age-based preference for
the red blood cells (RBC) they invade, with implications for
virulence and disease severity. CD47, a marker of self, prevents
the early clearance of cells by phagocytosis. We report here
that in the absence of CD47, growth of a Plasmodium species
that preferentially infects CD47hi
young RBC is highly attenu-
ated, and the macrophages from CD47−/−
mice are more ef-
fective in phagocytizing the malaria-parasitized RBC than wild-
type mice. We suggest that preferential invasion of young RBC
is an evolutionary adaptation that shields the malaria parasite
from phagocytic clearance and controls parasitemia, as fewer
RBC are available for invasion. Modulation of CD47 levels by
antibody treatment may have therapeutic value in patients
with severe malaria.
Author contributions: R.B. and S. Kumar designed research; R.B. and B.S. performed
research; R.B. and S. Khandelwal contributed new reagents/analytic tools; R.B., Y.K.,
and S. Kumar analyzed data; and R.B. and S. Kumar wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
1
To whom correspondence should be addressed. Email: sanjai.kumar@fda.hhs.gov.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1418144112/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1418144112 PNAS Early Edition | 1 of 6
IMMUNOLOGYAND
INFLAMMATION
2. of tumor cells in vitro, reduced their growth, and prevented the
metastasis of human patient tumor cells (14). In this article,
using the murine Plasmodium yoelii nonlethal model, we provide
quantitative evidence for age of RBC as the basis for the survival
and growth of malaria parasites and provide supporting data that
suggest that P. yoelii nonlethal parasites prefer to grow inside
younger RBC, which allows them to evade immune clearance by
phagocytic cells through a CD47-mediated process, and that
CD47 modulates the clearance of malaria infection. To our
knowledge, this is the first report that provides a molecular basis
for the age-dependent preference for infection of RBC by a
Plasmodium parasite and sheds light on its implications for the
severity of malaria infection in a host.
Results
In Vivo Biotinylation Allows Discrimination of Young Versus Aged RBC
and Measurement of Age-Based Preference for RBC Infection by
GFP-PyNL Parasites. We used a quantitative, biotin-labeling-based
procedure (16, 17) to examine the age of RBC as a factor for
invasion, growth, and survival of green fluorescent protein (GFP)
expressing P. yoelii 17XNL (GFP-PyNL) parasites in C57BL/6
mice. In vitro capturing of the biotin-RBC with streptavidin-
allophycocyanin (APC) was used to differentiate the young
(APC-negative) and aged (APC-positive) RBC by flow cytometry.
Data showed that three i.v. injections of biotin on consecutive days
transiently biotin-coated all of the existing RBC, and newly gener-
ated RBC released thereafter were free of biotin coat (Fig. S1). On
the day after the third biotin injection, C57BL/6 mice were infected
with the GFP-PyNL, and the differential infection in the young
(APC-negative) versus aged (APC-positive) RBC was measured
(Fig. 1A) on alternate days beginning from day 3 postinfection (p.i.)
and then followed throughout the course of infection by flow
cytometry; results were expressed as mean parasitemia (%) ± SEM
(Fig. 1B). To determine whether biotin administration influenced
the course of GFP-PyNL infection, parasitemias were compared in
biotin-injected mice versus those mice that did not receive any bi-
otin injection. Results showed that the ascending, peak, and clear-
ance phases of infection were comparable between the two groups
of mice (Fig. S2). As the infection progressed, the percentage of
newly released RBC increased dramatically after day 5 p.i. and
superseded the percentage of old RBC by day 9 p.i. (Fig. S1). The
parasites consistently showed a tendency to infect young RBC even
during the early phase of infection, which became more prominent
and statistically significant as the parasitemia rose [P < 0.005; two-
way analysis of variance (ANOVA), followed by Bonferroni post
hoc comparison test] and remained so during the clearance phase
(Fig. 1B). Thus, our results clearly demonstrated that GFP-PyNL
exhibits preferential infection of young RBC, particularly during the
acute phase of infection (days 7–11), when the parasites almost
exclusively prefer to infect the young RBC (Fig. 1B).
GFP-PyNL Parasites Preferentially Infect CD47hi
RBC. CD47 on RBC
helps to avoid early clearance from circulation and maintain
homeostasis (11, 12). To investigate the role of CD47 during
malaria, we measured the expression of CD47 in young and aged
RBC from biotin-injected C57BL/6 mice (Fig. 1C) during the
course of GFP-PyNL infection by flow cytometry; the results are
expressed as mean fluorescence intensity (MFI) ± SEM. We
find that young RBC expressed a higher level of CD47 (Fig. 1D).
After infection, the nonbiotin-tagged young and biotin-coated
aged RBC have a comparable level of CD47 expression up to day
5 p.i. However, as the parasitemia rose (days 7–11), young RBC
had significantly higher CD47 expression (P < 0.05; two-way
ANOVA followed by Bonferroni test) than aged RBC (Fig. 1D),
suggesting blood-stage PyNL infection induced the generation
of young CD47hi
RBC from day 7 p.i. onward, when the para-
sitemia becomes well established.
To further understand the correlation between CD47 level on
RBC and parasite burden, we investigated the CD47 levels on
parasitized and nonparasitized RBC during the course of GFP-
PyNL infection in C57BL/6 mice (Fig. 2A). Parasitized and
nonparasitized RBC were discriminated on the basis of the ex-
pression of GFP by the PyNL parasite. Results demonstrated
that compared with nonparasitized RBC, CD47 expression was
significantly higher (P < 0.0001; two-way ANOVA followed by
Bonferroni test) in parasitized RBC when the blood samples
from the same mice were measured throughout the course of
infection (Fig. 2B). We further differentiated the RBC pop-
ulations as the CD47lo
and CD47hi
, on the basis of CD47 in-
tensity on surface, and the parasite burden was measured in
the two groups of RBC (Fig. 2C). We find that the CD47hi
RBC
had significantly higher parasite burden than the population
of CD47lo
RBC during the acute phase (day 9 and day 12 p.i.;
P < 0.001, two-way ANOVA followed by Bonferroni test) of
infection (Fig. 2D). Together, these results demonstrated that
the highest infection and growth of PyNL parasites occurred in
the young CD47hi
RBC.
CD47 Phenotype Is Necessary to Support PyNL Growth. Having
established a direct relationship between the CD47 level of RBC
and parasite density, we next wanted to determine the role of
CD47 in the replication and survival of blood-stage parasites
in vivo. To accomplish this, we determined the effect of loss
of the CD47 phenotype on parasite growth by comparing the
Fig. 1. In vivo biotinylation separated young and aged populations of RBC that allowed determining the association between CD47 expression level and
parasitemia. Three dosages of biotin were administered in WT C57BL/6 mice (n = 5) on consecutive days, and on the following day, mice were infected with
GFP-PyNL pRBC. On the day of parasite challenge, 100% of RBC in all mice were biotin-coated, as determined by in vitro staining with streptavidin-APC (Fig.
S1). A gradual accumulation of young RBC was observed as the population of the aged RBC decreased during a 13-d observation period. (A) A representative
diagram showing the percentage GFP-PyNL parasitemia in young and aged populations of RBC in biotin-injected mice on day 9 p.i. (B) The parasite burden
during the course of infection was determined in the young and aged populations of RBC and plotted as the mean ± SEM. (C) CD47 intensity in the young and
aged populations of RBC in biotin-injected mice was assayed on day 9 after GFP-PyNL infection. (D) The CD47 levels on young and aged populations of RBC in
biotin-injected mice were measured throughout the course of infection and expressed as MFI values (mean ± SEM, n = 5). Bonferroni comparison test was
applied after two-way ANOVA.
2 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1418144112 Banerjee et al.
3. parasitemia during the course of infection with GFP-PyNL par-
asites in the wild-type (WT) and CD47−/−
mice by blood-film
microscopy. In one experiment (representative of four in-
dependent experiments conducted), WT C57BL/6 mice (n = 5)
developed an average parasitemia of 3.0 ± 0.25% on day 3 and
reached a peak parasitemia of 28.0 ± 5.8% on day 11, and then
the infection was self-resolved by day 17 p.i. In contrast, CD47−/−
mice developed a very low grade infection on day 3 (0.02 ±
0.02%) and maintained a lower parasitemia while reaching
a peak parasitemia of 2.98 ± 0.45% on day 7 that was completely
resolved by day 15 p.i. (Fig. 3). Thus, CD47−/−
mice reached an
early peak parasitemia by day 7 p.i. that was 9.3-fold lower than
the peak parasitemia of the WT mice that occurred on day 11 p.i.
These results clearly show that absence of CD47 negatively
regulates the growth of blood-stage GFP-PyNL parasites in mice.
In contrast to self-resolving PyNL, the P. yoelii YM (PyYM)
strain parasite invades both young and mature RBC and causes
uniformly fatal infection in mice. We also investigated the role of
CD47 in parasite clearance against the virulent PyYM parasite in
the C57BL/6 WT and CD47−/−
mice. The WT (n = 5) and
CD47−/−
(n = 5) mice were infected with the PyYM parasite, and
parasitemias were determined every day, beginning from day
3 p.i. After parasite challenge, the WT mice developed parasitemia
of 14.3 ± 0.95% on day 3, which rapidly rose to 53.6 ± 6.0% on day
5 p.i., at which point all mice in this group became moribund and
were killed. In contrast, CD47−/−
mice were highly resistant against
this virulent parasite and developed only 0.02 ± 0.008% on day 3,
reached a peak parasitemia of 0.06 ± 0.03 on day 4, and cleared
their infection by day 7 p.i. (Fig. S3). Thus, absence of CD47 con-
verted a highly virulent P. yoelii strain into a nonvirulent strain.
Modulation of CD47 Expression Affects the Parasite Burden and Host
Survival. To further ascertain that CD47 phenotype is a de-
terminant of malaria infectivity, we investigated the effect of
induced generation of young RBC on the outcome of GFP-PyNL
infection in the WT C57BL/6 mice. Phenyl hydrazine (PHZ),
a known anemia inducer, causes oxidative damage to the RBC,
followed by cell lysis that leads to the generation of new RBC to
maintain the homeostasis (18). After two consecutive injections
of PHZ in the WT mice, the packed cell volume of RBC dropped
significantly (60.4 ± 1.2% before PHZ treatment vs. 30.5 ± 4.2%
after PHZ treatment; Fig. S4; P = 0.0002, Student’s t test). Si-
multaneously, CD47 expression on RBC in PHZ-treated mice
was significantly higher than in untreated mice (MFI: 2,585.4 ±
71.8, PHZ treated group, vs. 1,425.2 ± 24.5, PHZ untreated
group; P < 0.0001, Student’s t test), confirming that the per-
centage of young RBC is significantly higher in the anemia-
induced model (Fig. S5). After GFP-PyNL infection, PHZ-treated
mice developed uncontrolled parasitemia (36.0 ± 13.2% in
PHZ-treated vs. 1.74 ± 0.25% in untreated mice on day 3 p.i.;
Fig. 4A; P = 0.0357, Mann–Whitney U test). The non-PHZ-treated
mice followed a course of parasitemia that was similar to that
observed in Fig. 3, and these mice self-resolved their infection by
day 17 p.i. In contrast, all PHZ-treated mice died of malaria by
day 5 p.i.
We also investigated the effect of down-regulation of CD47 level
by injecting an anti-CD47 neutralizing antibody and measured the
parasitemia after GFP-PyNL infection in the WT C57BL/6 mice. A
single administration of miap301, a mouse anti-CD47 neutralizing
antibody, on the day of GFP-PyNL infection caused a significant
reduction in parasite burden (neutralizing CD47 Ab-treated mice,
0.026± 0.008%; isotype Ab-treated mice, 0.39 ± 0.05%; Fig. 4B) on
day 3 p.i. (P = 0.0004, Student’s t test).
Together, these results clearly establish that CD47hi
RBC are
more amiable to supporting the growth of PyNL parasite. Fur-
thermore, a shift toward a population of CD47hi
RBC may
convert a nonlethal malaria infection into a lethal one, or con-
version toward a population of CD47lo
RBC may attenuate the
parasite virulence.
Immunologic Basis Underlying CD47-Mediated Resistance from
Malaria. We investigated an immunologic basis for the enhanced
resistance from malaria observed in CD47−/−
mice. To accomplish
this, we performed the flow cytometry analysis of splenic cells in
the GFP-PyNL-infected (day 7) WT and CD47−/−
mice. In the
splenic T-cell repertoire, in CD47−/−
mice, the percentage of
CD4+
T cells was 1.4-fold lower, but it was 1.3-fold higher for
CD8+
T cells than in the WT mice (Fig. S6). Simultaneously, the
percentage of γ/δ+
T cells was found to be twofold lower in the
CD47−/−
mice, whereas the differences between the natural killer
T (NKT) cell and B cell were not significant (Fig. S6). In-
terestingly, the percentage of F4/80+
tissue resident macrophages
was 1.8-fold higher in the CD47−/−
mice than the WT mice (Fig.
5A). The analysis of absolute numbers of the studied cell pop-
ulations showed no significant difference between the CD47−/−
and WT groups (Fig. 5B and Fig. S6). In addition, the serum cy-
tokine profiling was performed to gain an understanding of the
effect of cytokines toward the protection against PyNL infection in
the CD47−/−
mice. The eight cytokines (IL-2, IL-4, IL-5, IL-10,
IL-12, GM-CSF, TNF-alpha, and IFN-γ) were measured in the
serum of GFP-PyNL-infected CD47−/−
mice and WT mice on
day 7 p.i. (Fig. S7). Among the cytokines measured, serum IL-10
level was 1.9-fold lower in CD47−/−
mice than WT mice (Fig.
5C); flow cytometry results had revealed a 7.5-fold-lower IL-10
producing F4/80+
cells in CD47−/−
mice (Fig. 5D). These results
are in concordance with a previous report showing that IL-10−/−
mice were highly resistant to PyNL infection (19). No significant
changes in serum levels of IL-2, IL-4, IL-5, IL-12, TNF-α, IFN-γ,
and GM-CSF were observed (Fig. S7).
Fig. 2. GFP-PyNL parasites prefer to infect CD47hi
RBC. (A) The parasitized RBC (pRBC) and nonparasitized RBC (npRBC) were differentiated on the basis of
GFP expression by the GFP-PyNL, and the CD47 intensity was measured in the pRBC and npRBC groups assayed on day 9 post-GFP-PyNL infection. (B) The CD47
MFI of pRBC and npRBC from the same infected mouse (n = 10) were plotted throughout the course of infection. Statistically significant differences in the
CD47 MFI values were noted between the two groups (P < 0.0001). (C) A representative diagram shows the GFP-PyNL burden in CD47hi
and CD47lo
RBC
populations. (D) The percentage of parasitemia in the CD47lo
and CD47hi
group was plotted as mean ± SEM throughout the course of infection. Data were
analyzed using the two-way ANOVA followed by Bonferroni test.
Banerjee et al. PNAS Early Edition | 3 of 6
IMMUNOLOGYAND
INFLAMMATION
4. Enhanced Phagocytic Activity by Splenic F4/80 Macrophages in
GFP-PyNL-Infected CD47−/−
Mice. A major function of CD47 is to
interact with the signal regulatory protein alpha receptor and to
inhibit phagocytosis of young RBC by macrophages to maintain an
adequate level of RBC in circulation. We investigated whether the
GFP-PyNL-infected RBC were subjected to enhanced phagocytic
clearance by F4/80+
macrophages from the CD47−/−
mice com-
pared with those from the WT mice. F4/80+
is present on a wide
distribution of resident macrophages in the lymphohematopoietic
system, including in the red pulp area of spleen (20), a site known
for the clearance of aged RBC and cells expressing foreign antigens,
including infected RBC (20). GFP-PyNL-infected WT and CD47−/−
mice were killed on day 7 p.i., and the in vivo engulfment of
GFP-PyNL-infected RBC was measured in spleen cell suspension
by flow cytometry. We found that the percentage of F4/80+
mac-
rophages that had internalized GFP-PyNL-infected RBC was sig-
nificantly higher (P = 0.0005, Student’s t test) in the spleen cells
from the CD47−/−
mice than in WT mice (13.59 ± 1.2% CD47−/−
vs. 3.69 ± 0.7% WT; Fig. 5E). This suggests the enhanced
protection against malaria observed in the absence of CD47, at
least in part, may be attributed to enhanced susceptibility to
clearance of parasitized RBC by splenic macrophages during
PyNL infection.
Discussion
The RBC age-based preference for invasion by merozoites of
some Plasmodium species has important implications for malaria-
induced disease severity and host survival (1). Evidence from
human malarias and experimental models has established that
Plasmodium species that invade and grow inside young RBC are
generally benign in nature and cause a self-resolving infection. In
a healthy host, reticulocytes are only 1% of circulating RBC (21),
and even in the conditions of malaria anemia, the number of RBC
available for invasion becomes a limiting factor that prevents an
uncontrolled parasite growth, and infection is attenuated and self-
resolved. Why certain Plasmodia have evolved to infect only young
RBC is not fully understood.
CD47 is a marker of self on many cells, including RBC, and
RBC that lack CD47 are rapidly cleared by splenic macrophages
(12). In this article, we have quantitatively demonstrated that
PyNL parasites preferentially invade and grow inside the young
RBC and provide evidence for a direct relationship between the
CD47 intensity and parasite burden. We find that in the same
mouse, parasitized RBC had higher CD47 levels than non-
parasitized RBC, and CD47hi
RBC had a higher parasite burden
than CD47lo
RBC (Fig. 2 B and D). As the level of CD47 declined
in maturing RBC (Fig. S1), CD47lo
RBCs were less susceptible to
GFP-PyNL infection. Importantly, we find that the CD47 pheno-
type is essential to support the optimal replication of the GFP-PyNL
parasite (Fig. 3). CD47−/−
mice on the C57BL/6 background are
healthy and exhibit normal RBC counts and hematocrit (22).
Compared with WT mice, CD47−/−
mice maintained very low
parasite burden, and they cleared their infection at an accelerated
rate (Fig. 3). These results strongly suggest that the abundance of
CD47hi
RBC exacerbates malaria infection, whereas CD47lo
RBC
or RBC lacking CD47 were associated with less fulminant infection
or resistance against malaria. Interestingly, the absence of CD47
was also detrimental for the growth of a highly virulent strain of
P. yoelii that invades RBC of all ages. The CD47−/−
mice cleared
their infection after reaching the peak average parasitemia of <0.1%
on day 4 p.i., whereas their WT counterparts developed >50%
parasitemia on day 5 p.i (Fig. S3) and were killed. These results
indicate the possible role of CD47 as a receptor of RBC used by the
P. yoelii merozoites in the process of invasion, which is the subject of
ongoing investigation in our laboratory.
Studies searching for a possible immunologic basis underlying
the CD47-mediated enhanced immunity revealed that on day 7 p.i.,
infected CD47−/−
mice had reduced proportions of splenic CD4+
T
and γ/δ+
T cells (Fig. S6), but an increased proportion of CD8+
T
cells compared with WT mice. Notably, infected CD47−/−
mice had
a significantly higher proportion of F4/80+
splenic cells (Fig. 5A);
these F4/80+
cells also had a higher percentage of internalized
GFP-PyNL-infected RBC than the F4/80+
cells from the WT mice
(Fig. 5E). These results suggest that the absence of CD47 may
render the infected RBC more susceptible to splenic clearance
through phagocytic macrophages, which, at least in part, could be
responsible for the enhanced resistance to malaria observed in
Fig. 3. Absence of CD47 confers resistance against PyNL malaria. Course of
parasitemias in the CD47−/−
(n = 5) and the WT C57BL/6 mice (n = 5) after in-
fection with GFP-PyNL parasite and percentage parasitemia were expressed as
mean ± SEM. Data were compared using two-way ANOVA, followed by Bon-
ferroni test.
Fig. 4. Modulation of CD47 level affects the severity of GFP-PyNL infection.
(A) Two dosages of PHZ were given on consecutive days to WT C57BL/6 mice
(n = 5), and on the following day the PHZ-treated and PHZ-nontreated mice
were infected with GFP-PyNL. Parasitemia was measured on day 3; results
are shown as mean ± SEM values. (B) WT C57BL/6 mice (n = 5) were injected
with either the neutralizing anti-CD47 mAb (miap301) or an isotype control
antibody and were challenged with GFP-PyNL the same day. The parasite
burden was measured on day 3 p.i.; results are shown as mean ± SEM. The
percentage parasitemias between the neutralizing anti-CD47 antibody and
isotype control mice were compared using the Student’s t test (B), whereas
comparisons between the PHZ-treated and PHZ-nontreated mice were made
using Mann–Whitney U test (A).
4 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1418144112 Banerjee et al.
5. CD47−/−
mice; this is supported by an earlier report that absence of
CD47 on RBC is associated with their phagocytic clearance (12).
We also find that F4/80+
cells from infected CD47−/−
mice had
lower F4/80+
intracellular (Fig. 5D) and serum IL-10 levels (Fig.
5C) on day 7 p.i. Previously, IL-10 has been shown to suppress
immune effector mechanisms during PyNL infection; IL-10−/−
mice were able to clear a PyNL infection at significantly lower
parasitemia than their WT counterparts (19). The role of CD47
in driving malaria-specific immunity should be interpreted
with caution, as CD47−/−
mice had a significantly lower antigenic
load, which may have influenced the type of immune response
generated. We propose that the preferential invasion of young,
CD47hi
RBC by malaria parasites shields the parasitized RBC
from an early clearance by the splenic phagocytic cells in the
absence of immunity. However, the limited availability of young
RBC limits the ability of reticulocyte-preferring plasmodia to
allow uncontrolled growth, and such infections are resolved
without turning fulminant. This argument is further supported by
the observation that GFP-PyNL infection turns lethal when an
unlimited supply of young, CD47hi
RBC was made available by
inducing reticulocytosis by injections of PHZ (Fig. 4A). In the
absence of malaria infection, PHZ-treated mice were able to
slowly reconstitute their hematocrit and survived. Previously, it
has been reported that up-regulation of CD47 expression on
mouse hematopoietic cells can be achieved by external cytokine
and inflammatory stimuli, and that the level of CD47 determined
the fate of their phagocytic clearance (13).
CD47 was initially identified as a tumor antigen on human
ovarian cancer cells (23); since then, it has been found to be
overexpressed in several types of cancers (15). Many researchers
considered this as an immune evasion mechanism to avoid
clearance of cancer cells by phagocytic cells. Recent studies have
shown that injection of anti-CD47 mAbs facilitated the phago-
cytosis of cancer cells by macrophages and initiated an anti-
T-cell immune response. Thus, anti-CD47 antibody treatment is
being pursued as a strategy to overcome the immune tolerance
induced by high CD47 expression and permits the uncontrolled
growth of malignant tumors (15).
The complete picture of the role of CD47 in parasite invasion
and replication in RBC and its relative contribution in immune-
driven clearance of Plasmodium parasites and host pathogenesis
remain far from clear. However, we think that the preferential
invasion of CD47hi
young RBC may be an evolutionary adap-
tation that benefits the parasite by avoiding early parasite
clearance by macrophages and ensuring host survival, as the low
reticulocyte count renders the infection avirulent. Further stud-
ies to understand the role of CD47 in the invasion, replication,
and pathogenesis of the malaria parasites are ongoing. The po-
tential benefits include the regulation of parasite burden and
attenuation of severe disease by the injection of neutralizing anti-
CD47 antibody in young children and naive adults during a vir-
ulent Plasmodium infection.
Materials and Methods
Mice, Parasite, and Infection. Age-matched female WT and CD47−/−
mice
(B6.129S7-Cd47tm1Fpl/J) mice on the C57BL/6 background were obtained
from The Jackson Laboratory. Mice were maintained at the facilities at the
Center for Biologics Evaluation and Research (CBER) at Kensington, MD. This
study was done in accordance with the guidelines set forth for the care and
use of laboratory animals by the Food and Drug Administration. The pro-
tocol under which these studies were performed was approved by the In-
stitutional Animal Care and Use Committee of the CBER (Animal Study
Protocol 2002-21). PyNL, GFP-PyNL (24), and PyYM were used as the parasite
sources and delivered i.p. as 1 × 106
parasitized RBC to cause infection in the
experimental mice. The details of these procedures are provided in the SI
Materials and Methods.
Parasitemia, Hematocrit, and RBC Count. The course of parasitemia in the WT
and CD47−/−
C57BL/6 mice were determined by microscopy on Giemsa-
stained thin blood films. Hematocrit determination was done by measuring
the percentage of packed cell volume in whole blood, and results were
compared among the test groups. RBC count was determined using a he-
mocytometer. The detail of parasitemia measurement is provided in the SI
Materials and Methods.
CD47 MFI Measurement. To determine the CD47 expression on RBC, whole
blood was stained with anti-mouse CD47 antibody (miap301) tagged with
Fig. 5. Immunologic analysis of resistance to GFP-PyNL infection in CD47−/−
mice. The WT and CD47−/−
C57BL/6 mice were infected with GFP-PyNL, and spleen
cells from the day 7 p.i. mice were stained with anti-F4/80-Percp antibody; results were analyzed by flow cytometry. (A) Percentage of F4/80+
cell population in
GFP PyNL-infected WT and CD47−/−
mice are expressed as mean ± SEM. (B) Absolute number of F4/80+
cells in the WT and CD47−/−
mice on day 7 p.i. was
calculated and presented as mean ± SEM. (C) Serum IL-10 levels in the WT and CD47−/−
mice on day 7 p.i. were measured by the bioplex assay and presented
as picograms per milliliter. (D) Percentage of Il-10 cytokine producing F4/80+
cells was determined from the WT and CD47−/−
mice on day 7 p.i. (E) Percentage
of F4/80+
cells that internalized the GFP-PyNL parasitized RBC was measured by flow cytometry. The statistical methods used were Student’s t test (A, B, D, and E)
and repeated measure ANOVA (C).
Banerjee et al. PNAS Early Edition | 5 of 6
IMMUNOLOGYAND
INFLAMMATION
6. phycoerythrin cyanine 7 (PE-Cy7), and the MFI was measured by FACS Canto
II, as described in the SI Materials and Methods.
Biotin Assay. To determine the age of the RBC, RBC were biotin-coated by
three consecutive injections of biotin-X-NHS ester (Calbiochem), 1 mg each
dose, i.v. Biotin-labeled RBC were detected by flow cytometry, using
APC-streptavidin capturing in vitro. Mice were infected with 1 × 106
GFP-PyNL
parasitized RBC on the following day after the last biotin injection, and
parasitemia in young (biotin-streptavidin-negative) and aged (biotin-strep-
tavidin-positive) populations of RBC was measured by flow cytometry. The
detailed method is discussed in the SI Materials and Methods.
Induction of Anemia. Anemia in WT C57BL/6 mice was induced by i.p. injec-
tions of PHZ (60 mg/kg body weight; Sigma) on two consecutive days. The
anemic condition was monitored by hematocrit assay and by determining the
RBC count as described. On the day after the second PHZ injection, mice were
infected with 1 × 106
GFP-PyNL parasitized RBC, and parasitemia was mon-
itored by blood-film microcopy.
Phagocytosis Assay. The in vivo phagocytosis of parasitized RBC by the splenic
F4/80+
population was measured on day 7 of GFP-PyNL p.i. WT and CD47−/−
C57BL/6 mice. Briefly, single-cell suspension of splenocytes was prepared as
described previously (25), and after blocking with CD16/32 for 30 min (BD
Biosciences), the splenic cells were stained for 30 min with perCP-anti-F4/80
antibody (Biolegend). The percentage of macrophages that had engulfed
GFP-PyNL parasitized RBC was calculated on FACS Canto II.
In Vivo Neutralization of CD47. A single dose of anti-mouse CD47 neutralizing
monoclonal antibody (clone: miap301, 100 μg/dose; Biolegend) or rat IgG2a,
κ isotype control antibody (Biolegend) was administered by i.p. route in the
WT C57BL/6 mice and, on the same day, infected with the 1 × 106
GFP-PyNL
parasitized RBC i.p., and parasitemias were determined by blood-film mi-
croscopy in blood samples taken on day 3 p.i.
Flow Cytometry. The biotin-labeling-based RBC age determination, CD47
expression level in RBC, and percentage GFP-PyNL infection in RBC were
performed by flow cytometry, as described earlier, using a FACS Canto II and
the FACS Diva software (BD Biosciences). In addition, flow cytometry was
used for immunologic profiling. The intracellular cytokine assay was done in
the F4/80+
population for IL-10 cytokine. The absolute number of cell pop-
ulation was also determined from the total live splenic cells. The details of
the experimental procedure and information on the antibodies and their
sources and methods used for data analysis are provided in the SI Materials
and Methods.
Analysis of Serum Cytokines. Eight cytokines [IL-2, IL-4, IL-5, IL-10, IL-12 (p70),
GM-CSF, IFN-γ, and TNF-α] were quantitated in serum samples collected from
the WT and CD47−/−
C57BL/6 mice on day 7 p.i. with GFP-PyNL, using the Bio-
Plex Pro Mouse Cytokine 8-plex Th1/Th2 assay kit (Bio-Rad Laboratories).
Briefly, serum samples were incubated with beads coated with a capture an-
tibody, biotinylated detection antibody, and streptavidin-phycoerythrin con-
jugate and three wash steps were performed between each step. Data were
acquired using the Bio-Plex 200 reader, and cytokine quantity was determined
using Bio-Plex Manager software version 6.0 (Bio-Rad Laboratories).
Statistical Analysis. Two-way ANOVA followed by Bonferroni post hoc
comparison test was used for the percentage of parasitemia or CD47 intensity
based on days postinfection. These comparisons were made between young
RBC and aged RBC, parasitized RBC and nonparasitized RBC, CD47hi
and
CD47lo
, or WT and KO mice. Repeated-measure ANOVA was applied to make
comparisons of serum cytokine concentration level between WT and KO
mice. The rest of the data were analyzed using either Student’s t test or
Mann–Whitney U test.
ACKNOWLEDGMENTS. We thank Bryan Grabias for critically reading this
manuscript. This research was supported by intramural funding from the
Food and Drug Administration.
1. McQueen PG, McKenzie FE (2004) Age-structured red blood cell susceptibility and the
dynamics of malaria infections. Proc Natl Acad Sci USA 101(24):9161–9166.
2. Swardson-Olver CJ, et al. (2002) Plasmodium yoelii uses the murine Duffy antigen
receptor for chemokines as a receptor for normocyte invasion and an alternative
receptor for reticulocyte invasion. Blood 99(8):2677–2684.
3. Moreno A, et al. (2013) Plasmodium coatneyi in rhesus macaques replicates the multi-
systemic dysfunction of severe malaria in humans. Infect Immun 81(6):1889–1904.
4. McKenzie FE, Jeffery GM, Collins WE (2001) Plasmodium malariae blood-stage dy-
namics. J Parasitol 87(3):626–637.
5. McKenzie FE, Jeffery GM, Collins WE (2002) Plasmodium vivax blood-stage dynamics.
J Parasitol 88(3):521–535.
6. Gilles HM (1993) The malaria parasites. Essential malariology, eds Gilles HM, Warrell DA
(Arnold, London), pp 12–34.
7. Miller LH, Baruch DI, Marsh K, Doumbo OK (2002) The pathogenic basis of malaria.
Nature 415(6872):673–679.
8. Adams JH, et al. (1992) A family of erythrocyte binding proteins of malaria parasites.
Proc Natl Acad Sci USA 89(15):7085–7089.
9. Reed MB, et al. (2000) Targeted disruption of an erythrocyte binding antigen in
Plasmodium falciparum is associated with a switch toward a sialic acid-independent
pathway of invasion. Proc Natl Acad Sci USA 97(13):7509–7514.
10. Ménard D, et al. (2010) Plasmodium vivax clinical malaria is commonly observed in
Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107(13):5967–5971.
11. Burger P, Hilarius-Stokman P, de Korte D, van den Berg TK, van Bruggen R (2012)
CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 119(23):
5512–5521.
12. Oldenborg PA, et al. (2000) Role of CD47 as a marker of self on red blood cells. Science
288(5473):2051–2054.
13. Jaiswal S, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells
and leukemia cells to avoid phagocytosis. Cell 138(2):271–285.
14. Willingham SB, et al. (2012) The CD47-signal regulatory protein alpha (SIRPa) in-
teraction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA
109(17):6662–6667.
15. Chao MP, Weissman IL, Majeti R (2012) The CD47-SIRPα pathway in cancer immune
evasion and potential therapeutic implications. Curr Opin Immunol 24(2):225–232.
16. Hoffmann-Fezer G, et al. (1993) Biotin labeling as an alternative nonradioactive ap-
proach to determination of red cell survival. Ann Hematol 67(2):81–87.
17. Khandelwal S, Saxena RK (2006) Assessment of survival of aging erythrocyte in cir-
culation and attendant changes in size and CD147 expression by a novel two step
biotinylation method. Exp Gerontol 41(9):855–861.
18. Magnani M, Stocchi V, Cucchiarini L, Chiarantini L, Fornaini G (1986) Red blood cell
phagocytosis and lysis following oxidative damage by phenylhydrazine. Cell Biochem
Funct 4(4):263–269.
19. Couper KN, et al. (2008) IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells
modulates parasite clearance and pathology during malaria infection. PLoS Pathog
4(2):e1000004.
20. Morris L, Graham CF, Gordon S (1991) Macrophages in haemopoietic and other tissues
of the developing mouse detected by the monoclonal antibody F4/80. Development
112(2):517–526.
21. Bessman JD (1990) Reticulocytes. Clinical Methods: The history, physical, and labora-
tory examinations, eds Walker HK, Hall WD, Hurst JW (Butterworth, Boston), pp
735–738.
22. Lindberg FP, et al. (1996) Decreased resistance to bacterial infection and granulocyte
defects in IAP-deficient mice. Science 274(5288):795–798.
23. Poels LG, et al. (1986) Monoclonal antibody against human ovarian tumor-associated
antigens. J Natl Cancer Inst 76(5):781–791.
24. Ono T, Tadakuma T, Rodriguez A (2007) Plasmodium yoelii yoelii 17XNL constitutively
expressing GFP throughout the life cycle. Exp Parasitol 115(3):310–313.
25. Kumar S, Good MF, Dontfraid F, Vinetz JM, Miller LH (1989) Interdependence of CD4+
T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to
vaccine development. J Immunol 143(6):2017–2023.
6 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1418144112 Banerjee et al.